POULVAC TRT LYOPHILISATE FOR OCULONASAL SUSPENSION FOR TURKEYS
POULVAC TRT LYOPHILISATE FOR OCULONASAL SUSPENSION FOR TURKEYS
Authorised
- Turkey rhinotracheitis virus, strain Clone K, Live
Product identification
Medicine name:
POULVAC TRT LYOPHILISATE FOR OCULONASAL SUSPENSION FOR TURKEYS
Poulvac TRT Lyophilisat zur Herstellung einer Suspension zur okulonasalen Anwendung für Puten
Active substance:
- Turkey rhinotracheitis virus, strain Clone K, Live
Target species:
-
Turkey
Route of administration:
-
Nasal use
-
Ocular use
-
Nebulisation use
Product details
Active substance and strength:
-
Turkey rhinotracheitis virus, strain Clone K, Live3.20/log10 50% cell culture infectious dose1.00Dose
Pharmaceutical form:
-
Lyophilisate for oculonasal suspension
Withdrawal period by route of administration:
-
Nasal use
-
Turkey
-
All relevant tissues0day
-
-
-
Ocular use
-
Turkey
-
All relevant tissues0day
-
-
-
Nebulisation use
-
Turkey
-
All relevant tissues0day
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI01CD01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Germany
Available in:
-
Germany
Package description:
- Cardboard boxes containing 10 vials of 5,000 doses
- Cardboard boxes containing 10 vials of 2,000 doses
- Cardboard boxes containing 10 vials of 1,000 doses
- Cardboard boxes containing 1 vial of 5,000 doses
- Cardboard boxes containing 1 vial of 2,000 doses
- Cardboard boxes containing 1 vial of 1,000 doses
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
- Zoetis Deutschland GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
- Zoetis Manufacturing & Research Spain, S.L.
Responsible authority:
- Paul-Ehrlich-Institut
Authorisation number:
- PEI.V.01721.01.1
Date of authorisation status change:
Reference member state:
-
France
Procedure number:
- FR/V/0412/001
Concerned member states:
-
Austria
-
Belgium
-
Denmark
-
Germany
-
Greece
-
Italy
-
Netherlands
-
Portugal
-
Spain
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Combined File of all Documents
This document does not exist in this language (English). You can find it
in another language below.
German (PDF)
Published on: 31/10/2025
How useful was this page?: